PGE synthase
Prostagladin E synthase catalzyes the oxidoreduction of PGHS (prostaglandin endoperoxde h2) into PGE2(prostaglandin E2). It is implicated in physiological conditions such as fever, pain and arthritis etc.
Products for PGE synthase
- Cat.No. Product Name Information
-
GC15058
Benzydamine HCl
Benzydamine HCl is a locally-acting nonsteroidal anti-inflammatory drug with local anaesthetic and analgesic properties; selectively binds to prostaglandin synthetase and has notable in vitro antibacterial activity.
-
GC17707
Bismuth Subsalicylate
Prostaglandin G/H Synthase 1/2 inhibitor
-
GC40352
Cafestol
Cafestol is a natural diterpene which is abundant in unfiltered coffee.
-
GC18904
CAY10678
mPGES-1 Inhibitor III
Microsomal prostaglandin E synthase-1 (mPGES-1) converts the COX product PGH2 into the biologically active PGE2. -
GC38431
Dehydroevodiamine
Dehydroevodiamine is a major bioactive quinazoline alkaloid isolated from Evodiae Fructus, has an antiarrhythmic effect in guinea-pig ventricular myocytes.
-
GC38678
Ethyl Caffeate
Ethyl Caffeate is a natural phenolic compound isolated from Bidens pilosa.
-
GC16880
Flurbiprofen
Ansaid
Cyclooxygenase inhibitors -
GC14633
HPGDS inhibitor 1
H-PGDS Inhibitor I
HPGDS inhibitor -
GC36254
HPGDS inhibitor 2
HPGDS inhibitor 2 is a highly potent and selective hematopoietic prostaglandin D synthase (H-PGDS) inhibitor with an IC50 of 9.9 nM.
-
GC10564
HQL 79
human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor
-
GC36463
Limaprost
17α,20dimethylΔ2PGE1, 17α,20dimethylΔ2Prostaglandin E1
A stable, potent analog of PGE1 -
GC16607
Mesalamine
5-ASA
5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. -
GC11743
MF63
A potent, selective, and orally active mPGES-1 inhibitor
-
GC36649
mPGES1-IN-3
mPGES1-IN-3 (Compound 17d) is a potent and selective microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor, which exhibits excellent mPGES-1 enzyme (IC50: 8 nM), cell (A549 IC50: 16.24 nM) and human whole blood potency (IC50: 249.9 nM).
-
GC18700
PF-4693627
PF-4693627 is an orally bioavailable inhibitor of microsomal prostaglandin E (PGE) synthase-1 (mPGES-1; IC50 = 3 nM).
-
GC32038
PGS-IN-1 (KME-4)
KME-4
PGS-IN-1 (KME-4) is a potent inhibitor of prostaglandin synthetase (PGS) with an IC50 of 0.28 μM; also inhibits 5-lipoxygenase with an IC50 of 1.05 μM. -
GC11670
Pranoprofen
Pyranoprofen, Y 8004
non-steroidal COX inhibitor -
GC12330
SAR191801
SAR191801 is a hPGDS inhibitor ,with IC50 of 12 nM in the Fluorescence Polarization Assay or the EIA assay.
-
GN10280
Sinensetin
Pedalitin Permethyl ether
-
GC14438
Suprofen
NSC 303611, R 25061, (±)-Suprofen, TN 762
dual COX-1/COX-2 inhibitor -
GC50101
TFC 007
Potent hematopoietic prostaglandin D synthase (H-PGDS) inhibitor
-
GC70119
Vipoglanstat
BI 1029539; GS-248; OX-MPI
Vipoglanstat (BI 1029539), also known as formylamide, is an effective, selective, non-peptide small molecule inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1) with oral activity. Vipoglanstat also has anti-inflammatory activity.
-
GC63394
Zaloglanstat
ISC-27864; GRC-27864
Zaloglanstat (ISC-27864) is the inhibitor of the microsomal prostaglandin E synthase-1 (mPGES-1), and can be used to study asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases, etc. -
GC31687
Zomepirac sodium salt (McN-2783-21-98)
Zomepirac sodium salt (McN-2783-21-98) (McN-2783-21-98) is a potent prostaglandin biosynthesis inhibitor.